Search

Author/Creator Glue, Paul

2. A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression – the way to go? Results from a pilot randomised controlled trial. (February 2019)

Authors:
Gálvez Ortiz, Verónica; Glue, Paul; Somogyi, Andrew A; Martin, Donel; Alonzo, Angelo; Rodgers, Anthony; Mitchell, Philip B; Li, Adrienne; Huggins, Christina; Loo, Colleen K
Journal:
Journal of psychopharmacology
Issue:
Volume 33:Number 2(2019)
Page Start:
260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Ascending Single‐Dose, Double‐Blind, Placebo‐Controlled Safety Study of Noribogaine in Opioid‐Dependent Patients. Issue 6 (1st April 2016)

Authors:
Glue, Paul; Cape, Gavin; Tunnicliff, Donna; Lockhart, Michelle; Lam, Fred; Hung, Noelyn; Hung, C. Tak; Harland, Sarah; Devane, Jane; Crockett, R. S.; Howes, John; Darpo, Borje; Zhou, Meijian; Weis, Holger; Friedhoff, Lawrence
Journal:
Clinical pharmacology in drug development
Issue:
Volume 5:Issue 6(2016:Nov./Dec.)
Page Start:
460
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗